Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. As of February 2019, the Veterinary Medical Board in California still has no official policy on hemp products. Medical Cannabis in California. Related story.

Pets 218

Pets Legalization Hemp Extraction 218

Project CBD

JANUARY 31, 2023

26, the FDA issued a CBD policy statement that reaffirmed its longstanding unwillingness or inability to regulate nonpharmaceutical CBD products. ” As per usual, the FDA reflexively privileges pharmaceutical CBD, which is so safe it’s not even considered a controlled substance.

CBD 130

CBD Clinical Trials Pharmaceutical Food 130

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. Now, in 2015 — like in many other states throughout the country — we saw some fresh faces in the marijuana policy conversation. They managed to hold on to that.

Marijuana 231

Marijuana Legalization Programs Oil 231

Canna Law Blog

FEBRUARY 21, 2020

Specifically, the FSA is giving the CBD industry until March 31, 2021 to submit valid novel food authorization applications to ensure these products meet specific safety standards. Following the March 31, 2021 deadline, only products for which a valid application has been submitted will be allowed to remain on the market.

Food 121

Food CBD Legalization Hemp 121

NORML

FEBRUARY 23, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. Legislation is pending, House Bill 3960, to repeal the state’s zero tolerance per se traffic safety ban for THC and its metabolites.

Legislation 250

Legislation Patients Decriminalization Access 250

Cannabis Law Report

JUNE 17, 2021

Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. cannabis industry is failing to provide consumers and medical patients with much-needed guidance on appropriate use and crucial guarantees of product safety.

Policy 61

Policy Research and Development Medicine Safety 61

NORML

JANUARY 11, 2019

Update : The Criminal Justice and Public Safety Committee will hold an executive session for HB 399 on 1/17 at 11am. The measure would allow Virginia’s licensed practitioners to recommend and pharmaceutical processors to dispense full therapeutic-strength medical cannabis oil. NH resident? NY resident? New Mexico.

Legislation 213

Legislation Decriminalization Hemp Patients 213

Cannabis Law Report

JUNE 5, 2021

The Harare government has also approved the establishment of the Green Industry Fund, to promote local beneficiation, skills transfer and development of the local pharmaceutical industry. 100% foreign ownership a ‘significant departure from previous policy’.

Medicine 105

Medicine Pharmaceutical Agriculture Policy 105

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Here’s the press release. The Project on Psychedelics Law and Regulation (POPLAR).

Law 59

Law Policy Research and Development Clinical Trials 59

The Cannigma

MARCH 25, 2021

Executive Director of the Criminal Justice Policy Foundation told The Cannigma during a Zoom call this week. “A Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

NORML

FEBRUARY 29, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. The Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act (HR 3884 / S. NH resident?

Legislation 152

Legislation Decriminalization Patients Edibles 152

MMJ Recs

JUNE 26, 2020

Marijuana Use In Safety Sensitive Job Duties In Oklahoma. Safety Sensitive jobs and work duties were detailed. Employers were given the legal right to take MMJ use into account when their employees would be engaged in Safety Sensitive work. What Are Safety Sensitive Jobs In Oklahoma MMJ Law? Dispensing pharmaceuticals.

Marijuana 69

Marijuana Safety Pharmaceutical Patients 69

NORML

JANUARY 25, 2019

179: The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans. Update : The Criminal Justice and Public Safety Committee is holding a hearing on HB 481 on 2/5. NH resident? NH resident? New Mexico.

Legislation 166

Legislation Patients Hemp Oil 166

Cannabis Law Report

JUNE 2, 2021

and has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.” Pharmaceutical Grade CBD Oil. Idaho Office of Drug Policy: Cannabidiol (CBD): [link]. Idaho Code § 37-2701 et seq. A Schedule I substance is one that “has high potential for abuse.

Law 103

Law Marijuana Oil Pharmaceutical 103

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. 182 is scheduled for a hearing in the Health Policy Committee on 2/4/19 at 1:30 pm, 412 Knott Building. John Fetterman, Lt. Update : S.

Legislation 177

Legislation Decriminalization Access Patients 177

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. “ Off-label use ” (which is extremely common) is: the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

Therapy 107

Therapy Legalization Chronic Pain DEA 107

Cannabis Law Report

AUGUST 16, 2021

The Ridgell case is an appeal of the Department of Child Safety’s decision to keep a former employee of the department on the registry. Compared to the risks of the pharmaceuticals prescribed for HG that weren’t working, or the risk of having untreated HG, which is a one in three chance of a miscarriage? 10 donors.

Safety 116

Safety Patients Cannabis Law 116

Cannabis Law Report

JANUARY 10, 2020

Schlag has a keen interest in national and international drug policies, related regulatory challenges and public communications. CEO of Anspec and MD of Australia and Asia-Pacific for The Flowr Corporation, expert pharmaceutical supply and complex logistics, hi-tech manufacturing, consulting, public and private healthcare.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Medicine 59

Cannabis Law Report

NOVEMBER 24, 2019

If left to their own devices in Cannabis, a mixed bag of state regulations will continue to confuse the market as they rush to implement policies that are challenging for business and almost impossible for the consumer to understand. We all have to do better.

Business 95

Business Data Wellness and Beauty Safety 95

Cannabis Law Report

JULY 27, 2022

If a government chooses this lane, they have a responsibility to ensure safety, quality, and consistency. The next lane is pharmaceutical. This lane makes cannabis available to companies to develop pharmaceutical-grade medicines. These policy and commercial distinctions have taken hold around the globe.

Supply Chain 52

Supply Chain Pharmaceutical Policy Food 52

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 81

Law Research and Development Therapy DEA 81

Sensi Seeds

NOVEMBER 28, 2018

Then, a blog post circulated online, notifying the industry that Spain’s food and safety authority, AECOSAN, had updated its legislation to prohibit the sale and distribution of products containing CBD being sold as food supplements. Irrespective of where the directive came from, policy on CBD has changed.

CBD 71

CBD Seed-To-Sale Food Research and Development 71

Cannabis Law Report

AUGUST 23, 2021

Abernethy said, “We [FDA] remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety.”. He added that significant data is still needed to inform policy regarding use of consumer cannabis products.

Pets 105

Pets Hemp CBD Food 105

Veriheal

SEPTEMBER 7, 2022

But the reality is that those who choose cannabis for medical purposes and purchase it through an adult-use program miss out on benefits designed for patient accessibility and safety. One potential downside of an overly broad medical cannabis program is a patient registration rate that reduces the effectiveness of patient safety measures.

Patients 98

Patients Programs Access Treatment 98

Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. The Straits Times Reports. Cannabinoids are chemical compounds found in the cannabis plant.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

Cannabis Law Report

JUNE 9, 2022

9:45-10:45 AM: Federal cannabis policy: Coalition views on state and federal roles in a future national marketplace. Andrew Freedman, Executive Director, Coalition for Cannabis Policy, Education, and Regulation. 11:00-12:00 PM: Interstate Commerce: Impacts on markets, licensing, and consumer safety. Cannabis Council.

Policy 52

Policy Safety Seed-To-Sale Data 52

Canna Law Blog

JUNE 1, 2019

Schedule I is reserved for drugs with a high potential for abuse, no currently accepted medical uses, and a lack of accepted safety for medical use. The lone exception was a petition filed by the pharmaceutical manufacturer of Marinol, to move the synthetic cannabis drug from Schedule II to Schedule III. That one was granted.

DEA 108

DEA Marijuana History Cannabis 108

The Blunt Truth

DECEMBER 4, 2019

Specifically, the bill proposes to make it unlawful for an employer to take adverse action against an applicant or employee who is a qualified patient using medical marijuana consistent with state law, unless the position held or sought is one involving “safety-sensitive job duties.” The dispensing of pharmaceuticals.

Marijuana 65

Marijuana Safety Packaging State Laws 65

Cannabis Law Report

JANUARY 16, 2020

Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this. About Devonian. Devonian Health Group Inc.

Extraction 49

Extraction Pharmaceutical Research and Development Terpenes 49

Cannabis Law Report

MARCH 22, 2020

The Commission would be responsible for ensuring public safety by controlling and eliminating trafficking in prohibited narcotic drugs and prevent the illicit use of precursors, co-ordinating the treatment and rehabilitation of drug addicts. Some GH celebs just can’t hide their joy over this legalisation of Cannabis.

Media 59

Media Legalization Safety Legislation 59

Cannabis Law Report

JUNE 26, 2019

In May 2019, Florida Commissioner of Agriculture Nikki Fried announced that a newly-created and appointed Medical Marijuana Advisory Committee of 18 doctors, lawyers, patients, industry leaders, and advocates will be implemented in order to “advance and modernize policies” to move Florida into the future of medical marijuana.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Cannabis Law Report

JULY 30, 2019

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. Knowledge, attitudes and policies regarding medical cannabis and cannabis-based drugs are changing. Here are the takeaways ( Source Fitch).

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

Cannabis Law Report

FEBRUARY 18, 2020

The organisation is backed by CLEAR Cannabis Law Reform , the UK’s longest-standing cannabis policy group. The crucial part is that if they really had any genuine concern about safety, how could they possible give people only a year to submit an application?”. The report goes on to say.

CBD 59

CBD Food Medicine Pharmaceutical 59

Cannabis Law Report

JANUARY 3, 2022

CBD Product Safety and Standardization Act of 2021. The most recent legislation to debut on behalf of hemp, the CBD Product Safety and Standardization Act of 2021, was introduced this month by a bipartisan group of U.S. Hemp Access and Consumer Safety Act. representatives, including Reps. Hemp champion Sen. States Reform Act.

Hemp 52

Hemp Packaging Banking Food 52

Cannabis Law Report

JUNE 10, 2021

that demonstrate the safety and anti-inflammatory, anti-aging, and antimicrobial properties of Willow CBG on human skin. Willow is a Canadian biotechnology company that develops and produces high-purity, plant derived ingredients for consumer care, food and beverage, and pharmaceutical products. Forward-Looking Statements.

Research and Development 66

Research and Development Cannabinoids Pharmaceutical Policy 66

Cannabis Law Report

MARCH 26, 2022

A new commission for the United Kingdom (UK), the Hodges Review of UK Public Policy and Regulatory Stewardship of the Legal Cannabis Industry, will analyze its current legal cannabis industry and make recommendations on how to best maximize its growth, consumer satisfaction, and competitive potential on a global scale. All we’d say is.

Cannabinoids 52

Cannabinoids Research and Development Supply Chain Policy 52